KCNAB3

KCNAB3 encodes the voltage-gated potassium channel auxiliary subunit Kvβ3, which co-assembles with Kv1-family α-subunits to confer rapid A-type inactivation on otherwise slowly inactivating channels; co-expression of Kvβ3.1 with Kv1.5 in heterologous cells produces fast-inactivating outward potassium currents (PMID:9857044). A disease-causing missense mutation (H258R) in KCNAB3 accelerates channel inactivation and reduces potassium current amplitude when co-expressed with Kv1.1 in HEK293 cells, and a CRISPR knock-in mouse model carrying H258R confirms reduced potassium currents in hippocampal CA1 pyramidal neurons with increased neuronal excitability linked to epileptic seizures (PMID:32990398, PMID:36345448).

1. 1998 High

   Establishing the core function of Kvβ3: it was unknown whether Kvβ3.1 could confer A-type inactivation on Kv1 α-subunits; reconstitution with Kv1.5 demonstrated that Kvβ3.1 converts a slowly inactivating delayed-rectifier into a rapidly inactivating A-type potassium channel.

   Evidence Heterologous co-expression of Kvβ3.1 and Kv1.5 in CHO cells with electrophysiological recording

   PMID:9857044

   Open questions at the time

   • No in vivo confirmation that Kvβ3 confers A-type inactivation on native Kv1 channels
   • Structural basis of inactivation ball-and-chain mechanism for Kvβ3 not resolved
   • Selectivity of Kvβ3 for different Kv1 α-subunit partners not systematically tested
2. 2020 Medium

   Linking KCNAB3 to human disease: the H258R missense mutation was identified in epilepsy patients and shown to accelerate inactivation and reduce potassium current when co-expressed with Kv1.1, providing a mechanistic explanation for increased neuronal excitability.

   Evidence Whole-exome sequencing of epilepsy patients; patch-clamp electrophysiology in HEK293 cells co-expressing Kvβ3(H258R) with Kv1.1

   PMID:32990398

   Open questions at the time

   • Single-lab finding not independently replicated
   • Effect of H258R on assembly stoichiometry and trafficking of Kv1 channels not examined
   • Whether H258R affects the oxidoreductase-related fold of the aldo-keto reductase domain is unknown
3. 2022 Medium

   Validating the disease mechanism in vivo: a CRISPR knock-in mouse carrying H258R confirmed that mutant Kvβ3 reduces potassium currents in hippocampal CA1 pyramidal neurons, establishing that this β-subunit modulates native neuronal potassium channel function.

   Evidence CRISPR/Cas9 knock-in mouse; patch-clamp recording from hippocampal CA1 pyramidal cells

   PMID:36345448

   Open questions at the time

   • Single-lab study; independent replication needed
   • Whether the knock-in mouse exhibits spontaneous seizure phenotype not fully characterized
   • Contribution of Kvβ3 versus Kvβ1/Kvβ2 to native hippocampal channel complexes not resolved

• The tissue-specific expression, α-subunit selectivity, and potential aldo-keto reductase catalytic activity of Kvβ3 remain largely uncharacterized in vivo, and the structural basis for how disease mutations alter channel gating has not been determined.
• No crystal or cryo-EM structure of Kvβ3 in complex with a Kv1 α-subunit
• Enzymatic activity of the aldo-keto reductase domain of Kvβ3 not demonstrated
• Comprehensive tissue-level proteomics for Kvβ3 protein expression lacking